1. Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo. Toki S, Goleniewska K, Reiss S, Zhang J, Bloodworth MH, Stier MT, Zhou W, Newcomb DC, Ware LB, Stanwood GD, Galli A, Boyd KL, Niswender KD, Peebles RS (2018) J Allergy Clin Immunol 142(5): 1515-1528.e8
    › Primary publication · 29331643 (PubMed)
  2. Balanced high fat diet reduces cardiovascular risk in obese women although changes in adipose tissue, lipoproteins, and insulin resistance differ by race. Niswender KD, Fazio S, Gower BA, Silver HJ (2018) Metabolism : 125-134
    › Primary publication · 29382504 (PubMed)
  3. Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension. Trammell AW, Talati M, Blackwell TR, Fortune NL, Niswender KD, Fessel JP, Newman JH, West JD, Hemnes AR (2017) Pulm Circ 7(3): 624-634
    › Primary publication · 28704134 (PubMed) · PMC5841889 (PubMed Central)
  4. Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D. Chen Z, Zhang Y, Guo L, Dosoky N, de Ferra L, Peters S, Niswender KD, Davies SS (2017) J Lipid Res 58(8): 1624-1635
    › Primary publication · 28596183 (PubMed) · PMC5538284 (PubMed Central)
  5. Discovery of a Novel Series of Orally Bioavailable and CNS Penetrant Glucagon-like Peptide-1 Receptor (GLP-1R) Noncompetitive Antagonists Based on a 1,3-Disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione Core. Nance KD, Days EL, Weaver CD, Coldren A, Farmer TD, Cho HP, Niswender CM, Blobaum AL, Niswender KD, Lindsley CW (2017) J Med Chem 60(4): 1611-1616
    › Primary publication · 28103022 (PubMed)
  6. An insulin resistance associated neural correlate of impulsivity in type 2 diabetes mellitus. Eckstrand KL, Mummareddy N, Kang H, Cowan R, Zhou M, Zald D, Silver HJ, Niswender KD, Avison MJ (2017) PLoS One 12(12): e0189113
    › Primary publication · 29228027 (PubMed) · PMC5724830 (PubMed Central)
  7. The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview. Jefferson AL, Gifford KA, Acosta LM, Bell SP, Donahue MJ, Davis LT, Gottlieb J, Gupta DK, Hohman TJ, Lane EM, Libon DJ, Mendes LA, Niswender K, Pechman KR, Rane S, Ruberg FL, Su YR, Zetterberg H, Liu D (2016) J Alzheimers Dis 52(2): 539-59
    › Primary publication · 26967211 (PubMed) · PMC4866875 (PubMed Central)
  8. Imbalance in Resting State Functional Connectivity is Associated with Eating Behaviors and Adiposity in Children. Chodkowski BA, Cowan RL, Niswender KD (2016) Heliyon 2(1): e00058
    › Primary publication · 26878067 (PubMed) · PMC4750053 (PubMed Central)
  9. Disgust proneness and associated neural substrates in obesity. Watkins TJ, Di Iorio CR, Olatunji BO, Benningfield MM, Blackford JU, Dietrich MS, Bhatia M, Theiss JD, Salomon RM, Niswender K, Cowan RL (2016) Soc Cogn Affect Neurosci 11(3): 458-65
    › Primary publication · 26454815 (PubMed) · PMC4769631 (PubMed Central)
  10. Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake? Russell-Jones D, Danne T, Hermansen K, Niswender K, Robertson K, Thalange N, Vasselli JR, Yildiz B, Häring HU (2015) Diabetes Obes Metab 17(10): 919-27
    › Primary publication · 25974283 (PubMed) · PMC4744774 (PubMed Central)